Department of Veterans Affairs Pharmaceutical Procurement Policy: Hearing Before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Sixth Congress, Second Session, July 25, 2000U.S. Government Printing Office, 2001 - 92 sider |
Inni boken
Resultat 1-5 av 38
Side 1
... concern . We have a 10 - year history of vigilance to ensure that veterans re- ceive the VA drugs and medicines they need , and that VA doesn't have to spend an arm and a leg to get them . The pharmaceutical ( 1 ) industry , in the ...
... concern . We have a 10 - year history of vigilance to ensure that veterans re- ceive the VA drugs and medicines they need , and that VA doesn't have to spend an arm and a leg to get them . The pharmaceutical ( 1 ) industry , in the ...
Side 2
... concerned about our personal situ- ations . We are most concerned about the impact of such a plan on the VA health care system and its patients . So I take this hearing very seriously . My colleagues , let me quote from Mr. Flynn's ...
... concerned about our personal situ- ations . We are most concerned about the impact of such a plan on the VA health care system and its patients . So I take this hearing very seriously . My colleagues , let me quote from Mr. Flynn's ...
Side 3
... concerned about the rising costs of pharmaceuticals in recent years . For example , prescription drug premiums for fed- eral employees have increased by 30 percent in the past 3 years . Some Americans , most of them senior citizens ...
... concerned about the rising costs of pharmaceuticals in recent years . For example , prescription drug premiums for fed- eral employees have increased by 30 percent in the past 3 years . Some Americans , most of them senior citizens ...
Side 4
... Concerns have been raised that this program will adversely im- pact the VA . And we know that specifically that the concern is that it might increase VA prices for pharmaceuticals . And Mr. Chair- man , this concern is not unfounded ...
... Concerns have been raised that this program will adversely im- pact the VA . And we know that specifically that the concern is that it might increase VA prices for pharmaceuticals . And Mr. Chair- man , this concern is not unfounded ...
Side 8
... concerned to already see this starting to have an impact when it's not yet given . Is the Treasury already subsidiz- ing this proposed arrangement before the fact ? Does that make any sense ? Do you understand what I mean ? Mr. FLYNN ...
... concerned to already see this starting to have an impact when it's not yet given . Is the Treasury already subsidiz- ing this proposed arrangement before the fact ? Does that make any sense ? Do you understand what I mean ? Mr. FLYNN ...
Andre utgaver - Vis alle
Vanlige uttrykk og setninger
access to FSS Administration Agents Mutual Benefit BETZ BILIRAKIS Chairman Cliff Stearns COMMITTEE ON VETERANS concerned Congress contractor Cooperative Purchasing demonstration project Department of Veterans disabled veterans discounts DOYLE drug manufacturers drug prices EMPLOYEES HEALTH BENEFITS enrollees Federal Acquisition Regulation federal agencies FEDERAL EMPLOYEES HEALTH federal government Federal Supply Schedule FEHBP contracts FEHBP plans FLYNN FSS contracts FSS pricing going GUTIERREZ Health Benefits Plan Health Benefits Program health care health insurance hearing HELEN CHENOWETH-HAGE HIGPA members increases JACOB LEW JULY 25 Krump legislation Medicaid best price million Mutual Benefits Association National negotiations Office of Personnel OPM's percent pharmaceutical companies pharmaceutical industry pharmaceutical pricing PHARMACEUTICAL PROCUREMENT POLICY pilot program POWELL premiums prescription drugs price discrimination private sector retirees SAMBA health plan Saving Private Ryan SNYDER Special Agents Mutual Subcommittee on Health Supply Schedule FSS testimony Thank VA's Veterans Affairs WANNEMACHER
Populære avsnitt
Side 70 - American Federation of Government Employees, AFL-CIO 80 F Street, NW. Washington, DC 20001 * (202) 737-8700 * www.afge.ors Madam Chairwoman, Mr.
Side 23 - I shall look forward to reading in full your written statement which, without objection, will be made a part of the record immediately following any questions that the members of the subcommittee may have of this witness.
Side 52 - Cost-reimbursement types of contracts provide for payment of allowable incurred costs, to the extent prescribed in the contract. These contracts establish an estimate of total cost for the purpose of obligatiijp funds and establishing a ceiling that the contractor may not exceed (except at its own risk) without the approval of the contracting officer.
Side 86 - A firm-fixed-price contract provides for a price that is not subject to any adjustment on the basis of the contractor's cost experience in performing the contract. This contract type places upon the contractor maximum risk and full responsibility for all costs and resulting profit or loss. It provides maximum incentive for the contractor to control costs and perform effectively and imposes a minimum administrative burden upon the contracting parties.
Side 4 - The rebate program required drug manufacturers to give state Medicaid programs rebates for outpatient drugs. The rebates were based on the lowest or "best" prices they charged other purchasers.
Side 85 - FEKBP contract* are not authorized io have access tc the VA FSS Authorizing FEHBP contractors access to the VA FSS for prescription drugs would be contrary to the Federal Acquisition Regulations (FAR). Under the FAR 51.101, „ contractors may be authorized to use Government sources of supply in performing either Government cost reimbursement contracts, or in performing other types of negotiated contracts when the agency determines that a substantial portion of the contractor's contracts are of a...
Side 40 - HONORABLE JAMES B. KING, DIRECTOR OFFICE OF PERSONNEL MANAGEMENT . ; before the SUBCOMMITTEE ON CIVIL SERVICE COMMITTEE ON GOVERNMENT REFORM AND OVERSIGHT US HOUSE OF REPRESENTATIVES at a hearing on THE ADMINISTRATION'S WELFARE TO WORK PROGRAM APRIL 24, 1997 Mr.
Side 72 - Hamage and I am the National President of the American Federation of Government Employees, AFL-CIO (AFGE). On behalf of the more than 600,000 federal and District of Columbia employees our union represents, I thank you for the opportunity to testify today on the numerous problems plaguing the Federal Employees Health Benefits Program (FEHBP).
Side 63 - Mr. Chairman. I ask that my full statement be included in the record.
Side 18 - Carson, you are recognized for 5 minutes. Ms. CARSON. Thank you very much, Mr. Chairman.